In this webinar – ‘Enabling Digitally Enhanced Care for Rare Diseases in Europe: Integrating AI and Connected Care ...

With the annual cost estimated to be about ₹1 crore for each child requiring treatment for ultra-rare diseases, the Medical ...

Bengaluru: The medical education department is reaching out to corporate entities for support in treating children affected ...

GT-02287 oral presentation demonstrates new evidence of disease-modifying capacity in GBA1 and idiopathic Parkinson's disease ...

Biotech innovator Denali Therapeutics opened a new manufacturing hub as it develops new therapies for conditions like Hunter ...

This pre-recorded webinar was fully funded by Chiesi GRD and hosted by pharmaphorum. Professor Maurizio Scarpa received an ...

BENGALURU: Medical Education and Skill Development Minister Dr Sharan Prakash Patil has urged corporate houses, to adopt kids ...

Denali Therapeutics is a San Francisco-based biopharmaceutical company that develops drugs used in the treatment of neurodegenerative and lysosomal storage diseases, with a focus on drug delivery ...

Rocket Pharmaceuticals' gene therapies offer long-term effects for cardiovascular and hematology diseases. Read why I rate ...

The Indian government is addressing the challenges of rare diseases with a significant financial commitment. Minister ...

"Health being a state subject, the primary responsibility of providing healthcare services is that of state governments. However, to mitigate the challenges posed by rare diseases in India, the Union ...